Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.047x
Based on the latest financial reports, Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a cash flow conversion efficiency ratio of 0.047x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥327.19 Million) by net assets (CN¥6.95 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangzhou Kingmed Diagnostics Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Guangzhou Kingmed Diagnostics Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Kingmed Diagnostics Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wave Life Sciences Ltd
NASDAQ:WVE
|
-0.359x |
|
SHOU. HLDGS. LTD. (BL)
F:SHVA
|
N/A |
|
Guangdong Shenglu Telecommunication Tech Co Ltd
SHE:002446
|
-0.007x |
|
Perella Weinberg Partners
NASDAQ:PWP
|
0.295x |
|
Wilhelm Wilhelmsen Holding ASA
LSE:0P0T
|
0.009x |
|
Zhejiang Windey Co Ltd
SHE:300772
|
0.144x |
|
Sinochem International Corp
SHG:600500
|
0.046x |
|
ATAI Life Sciences BV
NASDAQ:ATAI
|
-0.145x |
Annual Cash Flow Conversion Efficiency for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.48 Billion | CN¥906.35 Million | 0.121x | -15.80% |
| 2023-12-31 | CN¥8.55 Billion | CN¥1.23 Billion | 0.144x | -34.39% |
| 2022-12-31 | CN¥8.87 Billion | CN¥1.95 Billion | 0.219x | -31.44% |
| 2021-12-31 | CN¥6.52 Billion | CN¥2.09 Billion | 0.320x | -18.53% |
| 2020-12-31 | CN¥3.88 Billion | CN¥1.52 Billion | 0.393x | +38.16% |
| 2019-12-31 | CN¥2.33 Billion | CN¥661.40 Million | 0.284x | +5.00% |
| 2018-12-31 | CN¥1.96 Billion | CN¥529.62 Million | 0.271x | +66.60% |
| 2017-12-31 | CN¥1.74 Billion | CN¥283.53 Million | 0.163x | -36.92% |
| 2016-12-31 | CN¥1.13 Billion | CN¥292.14 Million | 0.258x | +12.24% |
| 2015-12-31 | CN¥959.84 Million | CN¥220.39 Million | 0.230x | -60.20% |
| 2014-12-31 | CN¥391.72 Million | CN¥225.97 Million | 0.577x | +97.31% |
| 2013-12-31 | CN¥258.41 Million | CN¥75.55 Million | 0.292x | -32.66% |
| 2012-12-31 | CN¥203.69 Million | CN¥88.44 Million | 0.434x | -- |